Literature DB >> 10824130

Total deposition of therapeutic particles during spontaneous and controlled inhalations.

P Brand1, I Friemel, T Meyer, H Schulz, J Heyder, K Häubetainger.   

Abstract

Treatment of systemic diseases by means of the inhalation route is hampered by uncertainties of the drug dose applied by inhalation. In this study, the hypothesis was tested that by standardization of the breathing maneuver used for inhalation, the interindividual variability of the dose deposited intrathoracically can be reduced. Therefore, breathing pattern during routine inhalations with jet nebulizers was measured in 18 patients with lung disease. Using monodisperse 3 microm particles, total deposition was then assessed for the measured spontaneous and for three controlled, slow breathing patterns. Particle deposition for the three controlled breathing patterns was additionally measured in 14 healthy subjects. The study has shown that within the study population the inhaled air volume and flow rate were quite different. Consequently, total particle deposition varied between 20 and 95%, depending on breathing pattern. For controlled, slow breathing patterns, deposition was on average higher, intersubject variability of deposition was smaller, and differences in deposition between healthy subjects and patients were negligible. Therefore, to perform efficient systemic treatment with aerosolized drugs, controlled, slow breathing patterns should be used. Copyright 2000 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 89: 724-731, 2000

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10824130     DOI: 10.1002/(SICI)1520-6017(200006)89:6<724::AID-JPS3>3.0.CO;2-B

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  17 in total

1.  Micron-sized intrapulmonary particle deposition in the developing rat lung.

Authors:  Holger Schulz; Gunter Eder; Ines Bolle; Akira Tsuda; Stefan Karrasch
Journal:  J Appl Physiol (1985)       Date:  2011-12-08

2.  Inhaled insulin: take a deep breath, but how?

Authors:  Lutz Heinemann; Gerhard Scheuch; Tim Heise
Journal:  J Diabetes Sci Technol       Date:  2008-03

3.  Chemokine expression by small sputum macrophages in COPD.

Authors:  Marion Frankenberger; Christiane Eder; Thomas P J Hofer; Irene Heimbeck; Kerstin Skokann; Gudrun Kassner; Norbert Weber; Winfried Möller; Loems Ziegler-Heitbrock
Journal:  Mol Med       Date:  2011-02-09       Impact factor: 6.354

4.  A compartment-quasi-3D multiscale approach for drug absorption, transport, and retention in the human lungs.

Authors:  Ravishekar Ravi Kannan; Narender Singh; Andrzej Przekwas
Journal:  Int J Numer Method Biomed Eng       Date:  2018-01-25       Impact factor: 2.747

5.  Inflammation induced by inhaled lipopolysaccharide depends on particle size in healthy volunteers.

Authors:  Virginie Doyen; Gabrielle Pilcer; Phong Huy Duc Dinh; Francis Corazza; Alfred Bernard; Pierre Bergmann; Nicolas Lefevre; Karim Amighi; Olivier Michel
Journal:  Br J Clin Pharmacol       Date:  2016-07-28       Impact factor: 4.335

6.  The I-neb Adaptive Aerosol Delivery System enhances delivery of alpha1-antitrypsin with controlled inhalation.

Authors:  David E Geller; Kenneth C Kesser
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-04       Impact factor: 2.849

7.  A method for generating pulmonary neutrophilia using aerosolized lipopolysaccharide.

Authors:  Abraham B Roos; Tove Berg; Kerstin M Ahlgren; Johan Grunewald; Magnus Nord
Journal:  J Vis Exp       Date:  2014-12-15       Impact factor: 1.355

8.  Breath-by-breath measurement of particle deposition in the lung of spontaneously breathing rats.

Authors:  S Karrasch; G Eder; I Bolle; A Tsuda; H Schulz
Journal:  J Appl Physiol (1985)       Date:  2009-07-30

9.  Investigating pulmonary and systemic pharmacokinetics of inhaled olodaterol in healthy volunteers using a population pharmacokinetic approach.

Authors:  Jens Markus Borghardt; Benjamin Weber; Alexander Staab; Christina Kunz; Stephan Formella; Charlotte Kloft
Journal:  Br J Clin Pharmacol       Date:  2016-02-17       Impact factor: 4.335

10.  Low-dose endotoxin inhalation in healthy volunteers--a challenge model for early clinical drug development.

Authors:  Ole Janssen; Frank Schaumann; Olaf Holz; Bianca Lavae-Mokhtari; Lutz Welker; Carla Winkler; Heike Biller; Norbert Krug; Jens M Hohlfeld
Journal:  BMC Pulm Med       Date:  2013-03-28       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.